dagger 发表于 2025-3-25 04:15:13

http://reply.papertrans.cn/1/96/9572/9572-21.png

有偏见 发表于 2025-3-25 08:53:00

Submitted on: 28 May 2016.
Revised on: 23 June 2016.
Accepted on: 16 July 2016.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

Neolithic 发表于 2025-3-25 14:44:48

Submitted on: 30 January 2000.
Revised on: 16 March 2000.
Accepted on: 29 April 2000.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

没收 发表于 2025-3-25 16:53:34

Submitted on: 26 August 2024.
Revised on: 23 September 2024.
Accepted on: 08 November 2024.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

刺耳 发表于 2025-3-25 22:55:23

Submitted on: 10 March 2013.
Revised on: 13 June 2013.
Accepted on: 23 June 2013.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

semiskilled 发表于 2025-3-26 03:46:36

Submitted on: 13 May 2022.
Revised on: 15 July 2022.
Accepted on: 08 August 2022.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

Communicate 发表于 2025-3-26 04:26:25

http://reply.papertrans.cn/1/96/9572/9572-27.png

disciplined 发表于 2025-3-26 12:03:56

Submitted on: 16 July 2012.
Revised on: 19 August 2012.
Accepted on: 08 October 2012.

___________________Expert Review of Pharmacoeconomics & Outcomes Research

Radiation 发表于 2025-3-26 15:03:01

http://reply.papertrans.cn/1/96/9572/9572-29.png

不如乐死去 发表于 2025-3-26 19:59:52

Submitted on: 14 January 2017.
Revised on: 18 April 2017.
Accepted on: 23 May 2017.

___________________Expert Review of Pharmacoeconomics & Outcomes Research
页: 1 2 [3] 4
查看完整版本: SCIE期刊Expert Review of Pharmacoeconomics & Outcomes Research 2024/2025影响因子:1.856 (EXPERT REV PHARM OUT) (1473-7167). (P